Schwartz, D D <br/><br/>
Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.  [electronic resource] 

 -  Journal of veterinary pharmacology and therapeutics  Oct 1998 
 - 342-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0140-7783 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2885.1998.00151.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--pharmacology<br/>Animals<br/>Binding, Competitive<br/>Brain Stem--drug effects<br/>Hypnotics and Sedatives--pharmacology<br/>Imidazoles--pharmacology<br/>Ligands<br/>Receptors, Adrenergic, alpha-2--drug effects<br/>Sheep<br/>Tolazoline--pharmacology<br/>Yohimbine--pharmacology